Laubner, Katharina
University of Freiburg · University Medical Center Freiburg
5 papers on CoChatORCID 0000-0002-8303-5262
Most cited papers
- Verified
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial
Kroiss, M., Quinkler, M., Johanssen, S., van Erp, N. P., Lankheet, N., Pöllinger, A., Laubner, K., Strasburger, C. J., Hahner, S., Müller, H.-H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism
Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment
Cited by 175
- Verified
Impact of an acceptance facilitating intervention on diabetes patients' acceptance of Internet-based interventions for depression: A randomized controlled trial
Baumeister, H., Nowoczin, L., Lin, J., Seifferth, H., Seufert, J., Laubner, K., & Ebert, D. D. (2014) · Diabetes Research and Clinical Practice
Digital Mental Health InterventionsDiabetes Management and Education
Cited by 125
- Verified
Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic β-cells
Laubner, K., Kieffer, T. J., Lam, N. T., Niu, X., Jakob, F., & Seufert, J. (2005) · Diabetes
Pancreatic function and diabetesCytokine Signaling Pathways and Interactions
Cited by 85
- Verified
Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus
Roehlen, N., Laubner, K., Nicolaus, L., Schwacha, H., Bettinger, D., Krebs, A., Thimme, R., & Seufert, J. (2022) · Nutrition
Bariatric Surgery and OutcomesLiver Disease Diagnosis and Treatment
Cited by 17
- Verified
Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner
Riedel, N., Laubner, K., Lautenbach, A., Schön, G., Schlensak, M., Stengel, R., Eberl, T., Dederichs, F., Aberle, J., & Seufert, J. (2018) · Surgery for Obesity and Related Diseases
Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free